Back to Search
JAMES BURSTON, PH.D.
PH.D.
Addiction (Substance Use Disorder) Counselor
NPI: 1720149198Individual
Specialties, Licenses & Credentials
Addiction (Substance Use Disorder) CounselorPrimary
Counselor — Addiction (Substance Use Disorder)
Code: 101YA0400X
325(NC)
Research & Publications (8)
Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol.
PMID 19266526·ChemMedChem·2009
7-preclinical
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
PMID 19029917·Nat Chem Biol·2009
7-preclinical
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels.
PMID 18752948·Bioorg Med Chem Lett·2008
7-preclinical
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
PMID 18708079·Neuropharmacology·2008
7-preclinical
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.
PMID 18682568·J Pharmacol Exp Ther·2008
7-preclinical
CB1 cannabinoid receptor-mediated modulation of food intake in mice.
PMID 15778743·Br J Pharmacol·2005
4-observational
A discrete domain of the human TrkB receptor defines the binding sites for BDNF and NT-4.
PMID 11855816·Biochem Biophys Res Commun·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 857 KNOWLES RD, 1117 S. MAIN STREET
REIDSVILLE, NC 27320 - Phone
- (336) 342-3592
Quick Facts
- NPI
- 1720149198
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile